JP2004537564A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537564A5 JP2004537564A5 JP2003515500A JP2003515500A JP2004537564A5 JP 2004537564 A5 JP2004537564 A5 JP 2004537564A5 JP 2003515500 A JP2003515500 A JP 2003515500A JP 2003515500 A JP2003515500 A JP 2003515500A JP 2004537564 A5 JP2004537564 A5 JP 2004537564A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- het
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 921
- 125000003118 aryl group Chemical group 0.000 claims 786
- 125000000753 cycloalkyl group Chemical group 0.000 claims 777
- 125000000623 heterocyclic group Chemical group 0.000 claims 301
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 124
- 229910052757 nitrogen Inorganic materials 0.000 claims 124
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 112
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 90
- 125000001424 substituent group Chemical group 0.000 claims 69
- 229910052736 halogen Inorganic materials 0.000 claims 55
- 150000001875 compounds Chemical class 0.000 claims 47
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 45
- 125000001188 haloalkyl group Chemical group 0.000 claims 44
- 150000002367 halogens Chemical class 0.000 claims 43
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 33
- 125000005842 heteroatom Chemical group 0.000 claims 31
- 125000002877 alkyl aryl group Chemical group 0.000 claims 30
- 229910052760 oxygen Inorganic materials 0.000 claims 29
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 28
- 229910052717 sulfur Inorganic materials 0.000 claims 28
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 22
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 20
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 150000003536 tetrazoles Chemical class 0.000 claims 18
- 125000003342 alkenyl group Chemical group 0.000 claims 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 14
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 claims 13
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 12
- -1 bicycloalkenyl Chemical group 0.000 claims 12
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims 11
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 9
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 229920006395 saturated elastomer Polymers 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 4
- SDQJTWBNWQABLE-UHFFFAOYSA-N 1h-quinazoline-2,4-dione Chemical compound C1=CC=C2C(=O)NC(=O)NC2=C1 SDQJTWBNWQABLE-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 150000001540 azides Chemical class 0.000 claims 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 3
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims 3
- 229940091173 hydantoin Drugs 0.000 claims 3
- 229940124530 sulfonamide Drugs 0.000 claims 3
- 150000003456 sulfonamides Chemical class 0.000 claims 3
- 125000001425 triazolyl group Chemical group 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 2
- 108060004795 Methyltransferase Proteins 0.000 claims 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 2
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000005189 alkyl hydroxy group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 125000003435 aroyl group Chemical group 0.000 claims 2
- 150000001602 bicycloalkyls Chemical group 0.000 claims 2
- 235000010290 biphenyl Nutrition 0.000 claims 2
- 239000004305 biphenyl Substances 0.000 claims 2
- 239000007822 coupling agent Substances 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 239000002955 immunomodulating agent Substances 0.000 claims 2
- 229940121354 immunomodulator Drugs 0.000 claims 2
- 230000002584 immunomodulator Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical group N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims 1
- 229960003805 amantadine Drugs 0.000 claims 1
- 239000000010 aprotic solvent Substances 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 125000006269 biphenyl-2-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(*)C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 229960000329 ribavirin Drugs 0.000 claims 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30767401P | 2001-07-25 | 2001-07-25 | |
| US33806101P | 2001-12-07 | 2001-12-07 | |
| PCT/CA2002/001128 WO2003010141A2 (en) | 2001-07-25 | 2002-07-18 | Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009092397A Division JP2009275037A (ja) | 2001-07-25 | 2009-04-06 | ウイルスポリメラーゼインヒビター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004537564A JP2004537564A (ja) | 2004-12-16 |
| JP2004537564A5 true JP2004537564A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4398725B2 JP4398725B2 (ja) | 2010-01-13 |
Family
ID=26975871
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515500A Expired - Fee Related JP4398725B2 (ja) | 2001-07-25 | 2002-07-18 | ウイルスポリメラーゼインヒビター |
| JP2003515499A Expired - Fee Related JP4398241B2 (ja) | 2001-07-25 | 2002-07-18 | ウイルスポリメラーゼインヒビター |
| JP2009048600A Withdrawn JP2009120616A (ja) | 2001-07-25 | 2009-03-02 | ウイルスポリメラーゼインヒビター |
| JP2009092397A Withdrawn JP2009275037A (ja) | 2001-07-25 | 2009-04-06 | ウイルスポリメラーゼインヒビター |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515499A Expired - Fee Related JP4398241B2 (ja) | 2001-07-25 | 2002-07-18 | ウイルスポリメラーゼインヒビター |
| JP2009048600A Withdrawn JP2009120616A (ja) | 2001-07-25 | 2009-03-02 | ウイルスポリメラーゼインヒビター |
| JP2009092397A Withdrawn JP2009275037A (ja) | 2001-07-25 | 2009-04-06 | ウイルスポリメラーゼインヒビター |
Country Status (33)
Families Citing this family (209)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2450628A1 (en) * | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Benzothiophene compounds having antiinfective activity |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| US7294457B2 (en) | 2001-08-07 | 2007-11-13 | Boehringer Ingelheim (Canada) Ltd. | Direct binding assay for identifying inhibitors of HCV polymerase |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| US20050075279A1 (en) * | 2002-10-25 | 2005-04-07 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
| US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| GB0307891D0 (en) * | 2003-04-04 | 2003-05-14 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
| US7173004B2 (en) | 2003-04-16 | 2007-02-06 | Bristol-Myers Squibb Company | Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
| WO2004100947A2 (en) * | 2003-05-06 | 2004-11-25 | Smithkline Beecham Corporation | Novel chemical compounds |
| JP2007501189A (ja) | 2003-08-01 | 2007-01-25 | ジェネラブス テクノロジーズ，インコーポレイテッド | フラビウイルス科に対する二環式イミダゾール誘導体 |
| WO2005014543A1 (ja) * | 2003-08-06 | 2005-02-17 | Japan Tobacco Inc. | 縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用 |
| GB0321003D0 (en) | 2003-09-09 | 2003-10-08 | Angeletti P Ist Richerche Bio | Compounds, compositions and uses |
| US7112601B2 (en) | 2003-09-11 | 2006-09-26 | Bristol-Myers Squibb Company | Cycloalkyl heterocycles for treating hepatitis C virus |
| ATE500264T1 (de) | 2003-09-22 | 2011-03-15 | Boehringer Ingelheim Int | Makrozyklische peptide mit wirkung gegen das hepatitis-c-virus |
| CN1882333B (zh) * | 2003-10-07 | 2010-11-10 | 密执安州立大学董事会 | 吲哚抗病毒组合物 |
| GB0323845D0 (en) * | 2003-10-10 | 2003-11-12 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
| US20050119318A1 (en) * | 2003-10-31 | 2005-06-02 | Hudyma Thomas W. | Inhibitors of HCV replication |
| NZ595000A (en) | 2003-12-22 | 2013-03-28 | Gilead Sciences Inc | Imidazo[4,5-c]pyridine derivative for treating viral infections |
| DE602005025855D1 (de) | 2004-01-21 | 2011-02-24 | Boehringer Ingelheim Pharma | Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus |
| PT1718608E (pt) * | 2004-02-20 | 2013-08-01 | Boehringer Ingelheim Int | Inibidores da polimerase viral |
| US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| ATE428714T1 (de) | 2004-02-24 | 2009-05-15 | Japan Tobacco Inc | Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor |
| NZ550177A (en) * | 2004-03-08 | 2010-08-27 | Boehringer Ingelheim Pharma | Process for cross coupling indoles |
| US7126009B2 (en) * | 2004-03-16 | 2006-10-24 | Boehringer Ingelheim International, Gmbh | Palladium catalyzed indolization of 2-bromo or chloroanilines |
| GB0413087D0 (en) | 2004-06-11 | 2004-07-14 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| WO2007084413A2 (en) * | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) * | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| CA2573185A1 (en) | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| UY29017A1 (es) | 2004-07-16 | 2006-02-24 | Boehringer Ingelheim Int | Inhibidores de polimerasa viral |
| WO2006019832A1 (en) * | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| CA2574220C (en) | 2004-07-27 | 2014-09-16 | Gilead Sciences, Inc. | Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| RU2387655C2 (ru) * | 2004-08-09 | 2010-04-27 | Бристол-Маерс Сквибб Компани | Ингибиторы репликации вируса гепатита с |
| US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
| KR20070098914A (ko) * | 2005-01-14 | 2007-10-05 | 제네랩스 테크놀로지스, 인코포레이티드 | 바이러스 감염을 치료하기 위한 인돌 유도체 |
| RU2466126C2 (ru) | 2005-02-11 | 2012-11-10 | Берингер Ингельхайм Интернациональ Гмбх | Способ получения 2,3-дизамещенных индолов |
| JP4792048B2 (ja) | 2005-03-02 | 2011-10-12 | ファイブロゲン インコーポレイティッド | チエノピリジン化合物およびその使用方法 |
| MX2007013415A (es) | 2005-05-04 | 2008-01-15 | Hoffmann La Roche | Compuestos antivirales heterociclicos. |
| EP2546246A3 (en) | 2005-05-13 | 2013-04-24 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| EP1910337A2 (en) * | 2005-06-24 | 2008-04-16 | Genelabs Technologies, Inc. | Heteroaryl derivatives for treating viruses |
| JP5015154B2 (ja) * | 2005-08-12 | 2012-08-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ウイルスポリメラーゼインヒビター |
| WO2007023381A1 (en) * | 2005-08-24 | 2007-03-01 | Pfizer Inc. | Methods for the preparation of hcv polymerase inhibitors |
| JP2009523732A (ja) * | 2006-01-13 | 2009-06-25 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎の治療方法 |
| MX2008009581A (es) | 2006-01-27 | 2009-01-07 | Fibrogen Inc | Compuestos de cianoisoquinolina que estabilizan el factor inducible hipoxia (fih). |
| US7816348B2 (en) * | 2006-02-03 | 2010-10-19 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| JP2009526070A (ja) * | 2006-02-09 | 2009-07-16 | シェーリング コーポレイション | Ｈｃｖプロテアーゼ阻害薬とｈｃｖポリメラーゼ阻害薬との組み合わせ、ならびにそれらに関連する処置の方法 |
| MX2008011354A (es) * | 2006-03-03 | 2008-09-15 | Schering Corp | Combinaciones farmaceuticas de inhibidores de proteasa del virus de hepatitis c y del sitio interno de entrada ribosomal del virus de hepatitis c. |
| AU2007234408B2 (en) | 2006-04-04 | 2011-05-19 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
| EP1886685A1 (en) | 2006-08-11 | 2008-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| KR20090042973A (ko) | 2006-08-17 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 바이러스 폴리머라제 억제제 |
| MX2009002921A (es) | 2006-09-15 | 2009-04-01 | Schering Corp | Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico. |
| DK2084175T3 (da) | 2006-10-10 | 2011-04-18 | Medivir Ab | HCV nucleosidinhibitor |
| EP2463389A1 (en) | 2006-10-20 | 2012-06-13 | Innogenetics N.V. | Methodology for analysis of sequence variations within the HCV NS5B genomic region |
| AU2007321677B2 (en) | 2006-11-15 | 2013-04-11 | Vertex Pharmaceuticals (Canada) Incorporated | Thiophene analogues for the treatment or prevention of flavivirus infections |
| WO2008082488A1 (en) | 2006-12-22 | 2008-07-10 | Schering Corporation | 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| EP2081922B1 (en) | 2006-12-22 | 2012-02-01 | Schering Corporation | 5,6-Ring annulated indole derivatives and use thereof |
| JP5079818B2 (ja) | 2006-12-22 | 2012-11-21 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｈｃｖおよび関連するウイルス疾患の治療または予防のための４，５−環インドール誘導体 |
| CN101687789A (zh) * | 2007-02-12 | 2010-03-31 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| US7998951B2 (en) * | 2007-03-05 | 2011-08-16 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
| JP5211078B2 (ja) | 2007-03-13 | 2013-06-12 | ブリストル−マイヤーズ スクイブ カンパニー | シクロプロピル縮合インドロベンズアゼピンｈｃｖｎｓ５ｂ阻害剤 |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| JP2010526143A (ja) | 2007-05-04 | 2010-07-29 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｈｃｖ感染の処置のための併用療法 |
| CA2693495A1 (en) * | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| CA2693997C (en) * | 2007-08-03 | 2013-01-15 | Pierre L. Beaulieu | Viral polymerase inhibitors |
| JP5272008B2 (ja) * | 2007-08-29 | 2013-08-28 | メルク・シャープ・アンド・ドーム・コーポレーション | 置換インドール誘導体およびその使用の方法 |
| AR068107A1 (es) | 2007-08-29 | 2009-11-04 | Schering Corp | Derivados indolicos 2,3 sustituidos y una composicion farmaceutica |
| AU2008295485B2 (en) | 2007-08-29 | 2013-09-05 | Merck Sharp & Dohme Corp. | 2,3-substituted azaindole derivatives for treating viral infections |
| WO2009062288A1 (en) * | 2007-11-15 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Inhibitors of human immunodeficiency virus replication |
| WO2009064852A1 (en) * | 2007-11-16 | 2009-05-22 | Schering Corporation | 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| CN102099351A (zh) | 2007-11-16 | 2011-06-15 | 先灵公司 | 3-杂环取代的吲哚衍生物及其使用方法 |
| ES2463720T3 (es) | 2007-11-16 | 2014-05-29 | Gilead Sciences, Inc. | Inhibidores de la replicación del virus de inmunodeficiencia humana |
| WO2009076173A2 (en) | 2007-12-05 | 2009-06-18 | Enanta Pharmaceuticals, Inc. | Fluorinated tripeptide hcv serine protease inhibitors |
| CN101903351B (zh) | 2007-12-19 | 2014-09-10 | 贝林格尔.英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
| BRPI0821836A2 (pt) | 2007-12-24 | 2015-06-16 | Tibotec Pharm Ltd | Indóis macrocíclicos como inibidores do vírus da hepatite c |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| MX2010013630A (es) | 2008-06-13 | 2010-12-21 | Schering Corp | Derivados triciclicos de indol y metodos de uso de los mismos. |
| AR072559A1 (es) | 2008-07-15 | 2010-09-08 | Novartis Ag | Amidas sustituidas, composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades mediadas por dgat1. |
| WO2010018233A1 (en) | 2008-08-14 | 2010-02-18 | Tibotec Pharmaceuticals | Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| JP5539363B2 (ja) * | 2008-09-17 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | インターフェロンおよびリバビリンとのｈｃｖｎｓ３プロテアーゼ阻害剤の組合せ |
| AU2009314155B2 (en) | 2008-11-14 | 2015-10-08 | Fibrogen, Inc. | Thiochromene derivatives as HIF hydroxylase inhibitors |
| AU2009322400A1 (en) | 2008-12-03 | 2011-06-30 | Presidio Pharmaceuticals, Inc. | Inhibitors of HCV NS5A |
| AU2009322393B2 (en) | 2008-12-03 | 2017-02-02 | Presidio Pharmaceuticals, Inc. | Inhibitors of HCV NS5A |
| WO2010075376A2 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
| BRPI0922508A8 (pt) | 2008-12-23 | 2016-01-19 | Pharmasset Inc | Análogos de nucleosídeo |
| NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| SG172353A1 (en) | 2008-12-23 | 2011-07-28 | Abbott Lab | Anti-viral compounds |
| EP2376515A1 (en) | 2008-12-23 | 2011-10-19 | Pharmasset, Inc. | Synthesis of purine nucleosides |
| RU2011127080A (ru) | 2009-01-07 | 2013-02-20 | Сайнексис, Инк. | Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич |
| EP2385951A4 (en) | 2009-01-09 | 2013-05-29 | Univ Cardiff | PHOSPHORAMIDATE DERIVATIVES FROM GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS |
| WO2010091413A1 (en) * | 2009-02-09 | 2010-08-12 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
| US8314135B2 (en) * | 2009-02-09 | 2012-11-20 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole antivirals |
| US8242156B2 (en) * | 2009-02-17 | 2012-08-14 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
| US8188132B2 (en) * | 2009-02-17 | 2012-05-29 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
| US9765087B2 (en) | 2009-02-27 | 2017-09-19 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
| US8101643B2 (en) * | 2009-02-27 | 2012-01-24 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
| US8673954B2 (en) | 2009-02-27 | 2014-03-18 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
| US20190127365A1 (en) | 2017-11-01 | 2019-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
| DK2410844T3 (en) * | 2009-03-27 | 2016-07-04 | Merck Sharp & Dohme | Inhibitors of hepatitis C virus replication |
| JP5735482B2 (ja) | 2009-03-27 | 2015-06-17 | プレシディオ ファーマシューティカルズ インコーポレイテッド | 縮合環のｃ型肝炎阻害剤 |
| AU2010232729A1 (en) | 2009-03-31 | 2011-10-20 | Arqule, Inc. | Substituted indolo-pyridinone compounds |
| EP2417133A1 (en) | 2009-04-06 | 2012-02-15 | PTC Therapeutics, Inc. | Compounds and methods for antiviral treatment |
| CN102459165B (zh) * | 2009-04-15 | 2015-09-02 | Abbvie公司 | 抗病毒化合物 |
| CA2761650C (en) | 2009-05-13 | 2015-05-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic compounds as hepatitis c virus inhibitors |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| JP5530514B2 (ja) | 2009-06-11 | 2014-06-25 | アッヴィ・バハマズ・リミテッド | Ｈｃｖ感染を治療するための抗ウィルス化合物 |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| US8609648B2 (en) | 2009-07-02 | 2013-12-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| EP2475256A4 (en) * | 2009-09-11 | 2013-06-05 | Enanta Pharm Inc | HEPATITIS C-VIRUS HEMMER |
| US8822700B2 (en) * | 2009-09-11 | 2014-09-02 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| US8815928B2 (en) | 2009-09-11 | 2014-08-26 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| US8703938B2 (en) * | 2009-09-11 | 2014-04-22 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| US8927709B2 (en) * | 2009-09-11 | 2015-01-06 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| US8759332B2 (en) * | 2009-09-11 | 2014-06-24 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| PH12012500827A1 (en) | 2009-10-30 | 2013-01-07 | Boehringer Ingelheim Int | Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| JP2013511030A (ja) | 2009-11-14 | 2013-03-28 | エフ．ホフマン−ラ ロシュ アーゲー | Ｈｃｖ治療の迅速な反応を予測するためのバイオマーカー |
| JP2013512247A (ja) | 2009-11-25 | 2013-04-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | フラビウイルス感染症の治療または予防のための５−アルキニル−チオフェン−２−カルボン酸誘導体およびそれらの使用 |
| RU2012127201A (ru) | 2009-12-02 | 2014-01-20 | Ф.Хоффманн-Ля Рош Аг | Биомаркеры для прогнозирования устойчивого ответа на лечение вируса гепатита с |
| US8653070B2 (en) * | 2009-12-14 | 2014-02-18 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| SG181614A1 (en) | 2009-12-24 | 2012-07-30 | Vertex Pharma | Analogues for the treatment or prevention of flavivirus infections |
| US8933110B2 (en) | 2010-01-25 | 2015-01-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| WO2011091417A1 (en) | 2010-01-25 | 2011-07-28 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| CN101775003B (zh) * | 2010-02-04 | 2013-12-04 | 银杏树药业(苏州)有限公司 | 苯并噻吩类衍生物及其制备方法和应用 |
| US8178531B2 (en) * | 2010-02-23 | 2012-05-15 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
| US8623814B2 (en) * | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
| EP2542074A4 (en) * | 2010-03-04 | 2014-05-14 | Enanta Pharm Inc | PHARMACEUTICAL COMBINATION ACTIVE AGENTS AS HCV REPLICATION INHIBITORS |
| EP2550268A1 (en) | 2010-03-24 | 2013-01-30 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| TW201139438A (en) | 2010-03-24 | 2011-11-16 | Vertex Pharma | Analogues for the treatment or prevention of flavivirus infections |
| JP2013522375A (ja) | 2010-03-24 | 2013-06-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | フラビウイルス感染を処置または予防するためのアナログ |
| CN103038237A (zh) | 2010-03-24 | 2013-04-10 | 沃泰克斯药物股份有限公司 | 用于黄病毒感染治疗或预防的类似物 |
| WO2011123672A1 (en) | 2010-03-31 | 2011-10-06 | Pharmasset, Inc. | Purine nucleoside phosphoramidate |
| PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
| CN102858790A (zh) | 2010-03-31 | 2013-01-02 | 吉利德制药有限责任公司 | 核苷氨基磷酸酯 |
| US9127021B2 (en) | 2010-04-09 | 2015-09-08 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| AR082453A1 (es) | 2010-04-21 | 2012-12-12 | Novartis Ag | Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos |
| CA2800509A1 (en) | 2010-05-24 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| GB201012889D0 (en) | 2010-08-02 | 2010-09-15 | Univ Leuven Kath | Antiviral activity of novel bicyclic heterocycles |
| EP2575819A4 (en) | 2010-06-04 | 2013-11-27 | Enanta Pharm Inc | INHIBITORS OF HEPATITIS C VIRUS |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| EP2582717A2 (en) | 2010-06-15 | 2013-04-24 | Vertex Pharmaceuticals Incorporated | Hcv ns5b polymerase mutants |
| WO2012006070A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
| WO2012006060A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
| MX2012014918A (es) | 2010-06-28 | 2013-04-08 | Vertex Pharma | Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus. |
| WO2012021704A1 (en) | 2010-08-12 | 2012-02-16 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| AR082619A1 (es) | 2010-08-13 | 2012-12-19 | Hoffmann La Roche | Inhibidores del virus de la hepatitis c |
| WO2012024363A2 (en) | 2010-08-17 | 2012-02-23 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| GB201015411D0 (en) | 2010-09-15 | 2010-10-27 | Univ Leuven Kath | Anti-cancer activity of novel bicyclic heterocycles |
| US8648037B2 (en) | 2010-09-21 | 2014-02-11 | Enanta Pharmaceuticals, Inc. | Macrocyclic proline derived HCV serine protease inhibitors |
| WO2012040127A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| US8598183B2 (en) * | 2010-09-30 | 2013-12-03 | Boehringer Ingelheim International Gmbh | Solid state forms of a potent HCV inhibitor |
| CN103228278A (zh) | 2010-09-30 | 2013-07-31 | 贝林格尔.英格海姆国际有限公司 | 治疗hcv感染的组合疗法 |
| WO2012058125A1 (en) | 2010-10-26 | 2012-05-03 | Presidio Pharmaceuticals, Inc. | Inhibitors of hepatitis c virus |
| PT3042910T (pt) | 2010-11-30 | 2019-04-16 | Gilead Pharmasset Llc | 2'-espiro-nucleósidos para utilização na terapia da hepatite c |
| US9351989B2 (en) | 2010-12-29 | 2016-05-31 | Inhibitex, Inc. | Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
| WO2012107589A1 (en) | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
| WO2012123298A1 (en) | 2011-03-11 | 2012-09-20 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| CN103687489A (zh) | 2011-05-18 | 2014-03-26 | 埃南塔制药公司 | 制备5-氮杂螺[2.4]庚烷-6-甲酸及其衍生物的方法 |
| US20120328565A1 (en) | 2011-06-24 | 2012-12-27 | Brinkman John A | Antiviral compounds |
| WO2013016499A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Methods for preparation of thiophene compounds |
| AR087346A1 (es) | 2011-07-26 | 2014-03-19 | Vertex Pharma | Formulaciones de compuestos de tiofeno |
| HRP20180237T4 (hr) | 2011-09-16 | 2020-12-11 | Gilead Pharmasset Llc | Metode za liječenje hcv-a |
| EP2766365A1 (en) | 2011-10-10 | 2014-08-20 | F.Hoffmann-La Roche Ag | Antiviral compounds |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| WO2013086133A1 (en) | 2011-12-06 | 2013-06-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating viral diseases |
| ES2564906T3 (es) | 2011-12-16 | 2016-03-29 | F. Hoffmann-La Roche Ag | Inhibidores de NS5A del VHC |
| JP5982007B2 (ja) | 2011-12-20 | 2016-08-31 | リボサイエンス・エルエルシー | Ｈｃｖｒｎａ複製の阻害薬としての２’，４’−ジフルオロ−２’−メチル置換されたヌクレオシド誘導体 |
| WO2013092447A1 (en) | 2011-12-20 | 2013-06-27 | F. Hoffmann-La Roche Ag | 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication |
| CA2860234A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
| US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
| CA2857262A1 (en) | 2012-02-24 | 2013-08-29 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| HK1206362A1 (zh) | 2012-03-21 | 2016-01-08 | Alios Biopharma, Inc. | 硫代氨基磷酸酯核苷酸前藥的固體形式 |
| NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
| WO2013147750A1 (en) | 2012-03-27 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Oral combination therapy for treating hcv infection in specific patient sub-population |
| WO2013147749A1 (en) | 2012-03-27 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Oral combination therapy for treating hcv infection in specific patient subgenotype populations |
| US20130261134A1 (en) | 2012-03-30 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Mesylate salt forms of a potent hcv inhibitor |
| US9064551B2 (en) | 2012-05-15 | 2015-06-23 | Micron Technology, Inc. | Apparatuses and methods for coupling load current to a common source |
| US8976594B2 (en) | 2012-05-15 | 2015-03-10 | Micron Technology, Inc. | Memory read apparatus and methods |
| US20140010783A1 (en) | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
| US9064577B2 (en) | 2012-12-06 | 2015-06-23 | Micron Technology, Inc. | Apparatuses and methods to control body potential in memory operations |
| MX2015009176A (es) | 2013-01-23 | 2015-11-09 | Hoffmann La Roche | Derivados de triazola antivirales. |
| TWI685487B (zh) | 2013-01-24 | 2020-02-21 | 美商費比羅根公司 | ｛［１-氰基-５-（４-氯苯氧基）-４-羥基-異喹啉-３-羰基］-胺基｝-乙酸之晶形 |
| KR20140119012A (ko) | 2013-01-31 | 2014-10-08 | 길리어드 파마셋 엘엘씨 | 두 항바이러스 화합물의 병용 제형물 |
| TW201526899A (zh) | 2013-02-28 | 2015-07-16 | Alios Biopharma Inc | 醫藥組成物 |
| CA2900319A1 (en) | 2013-03-05 | 2014-09-12 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| WO2014138374A1 (en) | 2013-03-08 | 2014-09-12 | Boehringer Ingelheim International Gmbh | Oral combination therapy for treating hcv infection in specific patient sub-population |
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| RU2534613C2 (ru) | 2013-03-22 | 2014-11-27 | Александр Васильевич Иващенко | Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения |
| US20180200280A1 (en) | 2013-05-16 | 2018-07-19 | Riboscience Llc | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| BR112015028764B1 (pt) | 2013-05-16 | 2022-09-27 | Riboscience Llc | Derivados de nucleosídeo de 4-fluoro-2-metil substituídos como inibidores de replicação de rna do hcv |
| US9249176B2 (en) | 2013-05-16 | 2016-02-02 | Riboscience Llc | 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| US20150064253A1 (en) | 2013-08-27 | 2015-03-05 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
| GB2518639B (en) | 2013-09-26 | 2016-03-09 | Dyson Technology Ltd | A hand held appliance |
| EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
| MA44007A (fr) | 2016-02-05 | 2018-12-19 | Denali Therapeutics Inc | Inhibiteurs du récepteur interagissant avec protéine kinase 1 |
| PL3552017T3 (pl) | 2016-12-09 | 2022-08-08 | Denali Therapeutics Inc. | Związki użyteczne jako inhibitory RIPK1 |
| GB201701087D0 (en) | 2017-01-23 | 2017-03-08 | Univ Leuven Kath | Novel prodrugs of mizoribine |
| US10176880B1 (en) | 2017-07-01 | 2019-01-08 | Intel Corporation | Selective body reset operation for three dimensional (3D) NAND memory |
| KR102735678B1 (ko) | 2017-09-21 | 2024-11-27 | 리보사이언스 엘엘씨 | Hcv rna 복제의 억제제로서 4'-플루오로-2'-메틸 치환된 뉴클레오시드 유도체 |
| CN112996529B (zh) | 2018-10-02 | 2025-09-02 | 迪斯克医药公司 | Matriptase 2抑制剂及其用途 |
| AU2021213257C1 (en) * | 2020-01-29 | 2025-08-07 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| KR102318294B1 (ko) * | 2021-07-15 | 2021-10-26 | 이용화 | 친환경 교면방수제 조성물 및 이를 이용한 방수공법 |
| LT4426434T (lt) | 2021-11-02 | 2025-12-29 | Flare Therapeutics, Inc. | Pparg atvirkštiniai agonistai ir jų paskirtys |
| IL314082A (en) | 2022-01-12 | 2024-09-01 | Denali Therapeutics Inc | Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide |
Family Cites Families (160)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1094903A (en) | 1964-03-26 | 1967-12-13 | Smith Kline French Lab | Improvements in or relating to nitrofuran derivatives |
| FR1604809A (en) | 1965-11-26 | 1972-04-17 | Thiazolyl benzimidazoles - animal feed additives | |
| GB1186504A (en) | 1966-10-15 | 1970-04-02 | Fisons Pest Control Ltd | Substituted Heterocyclic Compounds |
| NL6917115A (cg-RX-API-DMAC7.html) | 1968-11-22 | 1970-05-26 | ||
| US3565912A (en) | 1969-01-27 | 1971-02-23 | Upjohn Co | 5-lower-alkanoyl-2,3-bis(p-methoxyphenyl)indoles |
| DE2346316C2 (de) | 1973-09-14 | 1985-02-14 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von 2-Furylbenzimidazolen |
| GB1521471A (en) | 1974-06-05 | 1978-08-16 | Randall & Son Ltd J | Token-deposit locks |
| FR2291749A1 (fr) | 1974-11-20 | 1976-06-18 | Delalande Sa | Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique |
| US4003908A (en) * | 1976-03-11 | 1977-01-18 | E. R. Squibb & Sons, Inc. | Derivatives of imidazo(4,5-b)pyridines |
| CH632628B (de) * | 1976-07-26 | Ciba Geigy Ag | Verfahren zur herstellung von benzofuranyl-benzimidazolen und deren verwendung als optische aufheller. | |
| DE2641060A1 (de) | 1976-09-11 | 1978-03-16 | Hoechst Ag | Beta-lactamverbindungen und verfahren zu ihrer herstellung |
| US4264325A (en) * | 1977-02-22 | 1981-04-28 | Ciba-Geigy Corporation | Phenyl-benzimidazolyl-furanes for optical brightening of organic materials |
| DE2720111A1 (de) | 1977-05-05 | 1978-11-16 | Agfa Gevaert Ag | Korrosionsschutzmittel fuer zweibad-stabilisatorbaeder |
| EP0010063B1 (de) | 1978-10-04 | 1982-12-29 | Ciba-Geigy Ag | Verfahren zur Herstellung von Furanyl-benzazolen |
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| DE2852531A1 (de) | 1978-12-05 | 1980-06-19 | Bayer Ag | Benzofuranyl-benzimidazole |
| DE2853765A1 (de) | 1978-12-13 | 1980-06-26 | Bayer Ag | Verfahren zur herstellung von benzimidazolylbenzofuranen |
| DE2904829A1 (de) | 1979-02-08 | 1980-08-14 | Bayer Ag | Verfahren zur herstellung von benzimidazolylbenzofuran |
| DE3069775D1 (en) * | 1979-11-01 | 1985-01-17 | Ciba Geigy Ag | Salts of cationic brighteners, their preparation and their use on organic materials as well as their concentrated aqueous solutions |
| GR75101B (cg-RX-API-DMAC7.html) | 1980-10-23 | 1984-07-13 | Pfizer | |
| GB8707798D0 (en) | 1987-04-01 | 1987-05-07 | Ici Plc | Recovery of metals |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| GB2118552A (en) | 1982-04-15 | 1983-11-02 | Pfizer Ltd | Thromboxane synthetase inhibitors |
| JPS60149502A (ja) | 1984-01-12 | 1985-08-07 | Kuraray Co Ltd | インド−ル系農園芸用殺菌剤 |
| US4613990A (en) * | 1984-06-25 | 1986-09-23 | At&T Bell Laboratories | Radiotelephone transmission power control |
| LU85544A1 (fr) | 1984-09-19 | 1986-04-03 | Cird | Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique |
| DE3522230A1 (de) | 1985-06-21 | 1987-01-02 | Thomae Gmbh Dr K | Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| GB8609175D0 (en) * | 1986-04-15 | 1986-05-21 | Ici America Inc | Heterocyclic carboxamides |
| GB8707051D0 (en) * | 1986-04-15 | 1987-04-29 | Ici America Inc | Heterocyclic carboxamides |
| US4859684A (en) * | 1986-09-15 | 1989-08-22 | Janssen Pharmaceutica N.V. | (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders |
| US4957932A (en) | 1987-11-25 | 1990-09-18 | Merck Frosst Canada, Inc. | Benzoheterazoles |
| JP2700475B2 (ja) | 1988-07-30 | 1998-01-21 | コニカ株式会社 | 非線形光学材料および非線形光学素子 |
| JPH03157646A (ja) | 1989-11-15 | 1991-07-05 | Konica Corp | ハロゲン化銀写真感光材料 |
| JPH03219232A (ja) | 1990-01-24 | 1991-09-26 | Konica Corp | 分光増感されたハロゲン化銀写真感光材料 |
| CA2077897A1 (en) | 1990-04-13 | 1991-10-14 | Robert G. Franz | Substituted benzimidazoles |
| JP2909645B2 (ja) | 1990-05-28 | 1999-06-23 | コニカ株式会社 | ハロゲン化銀カラー写真感光材料 |
| ES2130170T3 (es) | 1990-12-14 | 1999-07-01 | Smithkline Beecham Corp | Composiciones bloqueantes del receptor de la angiotensina ii. |
| US5527819A (en) * | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| PT100905A (pt) | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| GB9121463D0 (en) | 1991-10-10 | 1991-11-27 | Smithkline Beecham Corp | Medicament |
| GB9122590D0 (en) * | 1991-10-24 | 1991-12-04 | Lilly Industries Ltd | Pharmaceutical compounds |
| JPH05165163A (ja) | 1991-12-11 | 1993-06-29 | Konica Corp | 色素画像形成方法 |
| JP3013124B2 (ja) | 1991-12-26 | 2000-02-28 | コニカ株式会社 | カラー画像形成方法 |
| US5216003A (en) * | 1992-01-02 | 1993-06-01 | G. D. Searle & Co. | Diacid-containing benzimidazole compounds for treatment of neurotoxic injury |
| GB9203798D0 (en) | 1992-02-21 | 1992-04-08 | Fujisawa Pharmaceutical Co | Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| US5314796A (en) | 1992-04-02 | 1994-05-24 | Konica Corporation | Silver halide color photographic light sensitive material |
| US5387600A (en) | 1992-07-30 | 1995-02-07 | Fuji Photo Film Co., Ltd. | Treating arteriosclerosis using benzimidazole compositions |
| DE4237617A1 (de) * | 1992-11-06 | 1994-05-11 | Bayer Ag | Verwendung von substituierten Benzimidazolen |
| DE4237557A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituierte Benzimidazole |
| EP0672031B1 (en) | 1992-12-02 | 2003-03-12 | Pfizer Inc. | Catechol diethers as selective pde iv inhibitors |
| JP3213426B2 (ja) * | 1993-02-19 | 2001-10-02 | エーザイ株式会社 | ６，７−ジヒドロ−５Ｈ−シクロペンタ〔ｄ〕ピリミジン誘導体 |
| DE69434016T2 (de) | 1993-03-04 | 2005-02-10 | Fuji Photo Film Co., Ltd., Minami-Ashigara | Photographisches Silberhalogenidmaterial |
| DE4309969A1 (de) | 1993-03-26 | 1994-09-29 | Bayer Ag | Substituierte heteroanellierte Imidazole |
| US6169107B1 (en) * | 1993-04-28 | 2001-01-02 | Sumitomo Pharmaceutical Co., Ltd. | Indoloylguanidine derivatives |
| JP3156444B2 (ja) | 1993-06-02 | 2001-04-16 | 松下電器産業株式会社 | 短波長レーザ光源およびその製造方法 |
| DE4330959A1 (de) | 1993-09-09 | 1995-03-16 | Schering Ag | Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| DE59509233D1 (de) | 1994-02-24 | 2001-06-13 | Haarmann & Reimer Gmbh | Kosmetische und dermatologische zubereitungen, enthaltend phenylen-1,4-bisbenzimidiazolesulfonsäuren |
| CA2124169A1 (en) | 1994-05-24 | 1995-11-25 | Richard Mcculloch Keenan | Chemical compounds |
| AU2534295A (en) | 1994-05-27 | 1995-12-21 | James Black Foundation Limited | Gastrin and cck antagonists |
| RU2137759C1 (ru) * | 1994-11-29 | 1999-09-20 | Дайниппон Фармасьютикал Ко., Лтд. | Производное индола |
| EP0717143A1 (de) | 1994-12-16 | 1996-06-19 | Lignozym GmbH | Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung |
| DE19507913C2 (de) | 1995-03-07 | 1998-04-16 | Agfa Gevaert Ag | Farbfotografisches Silberhalogenidmaterial |
| ATE219765T1 (de) | 1995-04-10 | 2002-07-15 | Fujisawa Pharmaceutical Co | Indolderivate als cgmp-pde inhibitoren |
| CN1187812A (zh) * | 1995-04-10 | 1998-07-15 | 藤泽药品工业株式会社 | 作为环状乌苷3',5'－一磷酸盐磷酸二酯酶抑制剂的吲哚衍生物 |
| US6444694B1 (en) | 1995-06-06 | 2002-09-03 | Wyeth | Styryl benzimidazole derivatives |
| JP3544245B2 (ja) | 1995-06-09 | 2004-07-21 | 富士写真フイルム株式会社 | ハロゲン化銀カラー写真感光材料の処理方法 |
| WO1997006141A1 (en) * | 1995-08-04 | 1997-02-20 | Otsuka Kagaku Kabushiki Kaisha | Indole-2-carboxylic ester derivatives and agricultural and horticultural bacteriocides containing the same as the active ingredient |
| US5950124A (en) * | 1995-09-06 | 1999-09-07 | Telxon Corporation | Cellular communication system with dynamically modified data transmission parameters |
| AU6966696A (en) | 1995-10-05 | 1997-04-28 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
| DK0866059T3 (da) * | 1995-10-05 | 2002-03-25 | Kyoto Pharma Ind | Nye heterocykliske derivater og medicinsk anvendelse deraf |
| JPH09124632A (ja) | 1995-10-31 | 1997-05-13 | Sankyo Co Ltd | ベンゾヘテロ環誘導体 |
| CA2241186C (en) | 1995-12-28 | 2006-02-14 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| US5850592A (en) * | 1996-01-11 | 1998-12-15 | Gte Internetworking Incorporated | Method for self-organizing mobile wireless station network |
| JP2803626B2 (ja) * | 1996-04-05 | 1998-09-24 | 日本電気株式会社 | 移動無線端末の送信電力制御方式 |
| GB9610811D0 (en) | 1996-05-23 | 1996-07-31 | Pharmacia Spa | Combinatorial solid phase synthesis of a library of indole derivatives |
| EP2223920A3 (en) | 1996-06-19 | 2011-09-28 | Aventis Pharma Limited | Substituted azabicyclic compounds |
| GB9614347D0 (en) | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
| AUPO118896A0 (en) | 1996-07-23 | 1996-08-15 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| ES2273369T3 (es) | 1996-08-28 | 2007-05-01 | Pfizer Inc. | Derivados 6,5 heterobiciclicos sustituidos. |
| JPH10114654A (ja) | 1996-10-09 | 1998-05-06 | Fujisawa Pharmaceut Co Ltd | 新規用途 |
| DE69705324T2 (de) * | 1996-12-26 | 2001-10-11 | Nikken Chemicals Co., Ltd. | N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen |
| JPH10204059A (ja) | 1997-01-22 | 1998-08-04 | Ono Pharmaceut Co Ltd | フェニルスルホンアミド誘導体 |
| EP0968206B8 (en) | 1997-02-19 | 2007-01-24 | Berlex, Inc. | N-heterocyclic derivatives as nos inhibitors |
| WO1998037069A1 (en) | 1997-02-20 | 1998-08-27 | Shionogi & Co., Ltd. | Indole dicarboxylic acid derivatives |
| US6089156A (en) * | 1997-03-21 | 2000-07-18 | Heidelberger Druckmaschinen Aktiengesellschaft | Turning device for a printing press |
| US5932743A (en) * | 1997-08-21 | 1999-08-03 | American Home Products Corporation | Methods for the solid phase synthesis of substituted indole compounds |
| DE19753522A1 (de) | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel |
| SE9704545D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| SE9704544D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Pharma Prod | Novel compounds |
| CA2312484A1 (en) | 1997-12-11 | 1999-06-17 | Smithkline Beecham Corporation | Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| JPH11177218A (ja) | 1997-12-12 | 1999-07-02 | Tamura Kaken Co Ltd | 電子回路用金属面具備部品及びその表面保護剤 |
| US6104512A (en) * | 1998-01-23 | 2000-08-15 | Motorola, Inc. | Method for adjusting the power level of an infrared signal |
| KR100291413B1 (ko) * | 1998-03-02 | 2001-07-12 | 김영환 | 이동통신단말기의송신전력제어장치 |
| CN1311675A (zh) | 1998-05-22 | 2001-09-05 | 阿文尼尔药品公司 | 具有lgE影响性能的化合物 |
| US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
| DE69917777T2 (de) | 1998-06-18 | 2005-08-04 | Novartis Ag | Benzazol-verbindungen und ihre verwendung |
| US7223879B2 (en) * | 1998-07-10 | 2007-05-29 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| ES2244204T3 (es) | 1998-07-27 | 2005-12-01 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Derivados de dicetoacidos como inhibidores de polimerasas. |
| WO2000006556A1 (en) | 1998-07-27 | 2000-02-10 | Abbott Laboratories | Substituted oxazolines as antiproliferative agents |
| US6228868B1 (en) * | 1998-07-27 | 2001-05-08 | Abbott Laboratories | Oxazoline antiproliferative agents |
| BR9913157A (pt) | 1998-08-21 | 2001-05-15 | Viropharma Inc | Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto |
| CA2343522A1 (en) | 1998-09-04 | 2000-03-16 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
| AU751457B2 (en) | 1998-09-25 | 2002-08-15 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| IL142893A0 (en) | 1998-11-12 | 2002-04-21 | Neurocrine Biosciences Inc | Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same |
| US6531475B1 (en) | 1998-11-12 | 2003-03-11 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| US6358992B1 (en) | 1998-11-25 | 2002-03-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with indole derivatives |
| US6869950B1 (en) | 1998-12-24 | 2005-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| WO2000059902A2 (en) * | 1999-04-02 | 2000-10-12 | Du Pont Pharmaceuticals Company | Aryl sulfonyls as factor xa inhibitors |
| DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| JP2001122855A (ja) | 1999-10-27 | 2001-05-08 | Japan Tobacco Inc | インドール化合物及びその医薬用途 |
| US6346493B1 (en) * | 1999-10-27 | 2002-02-12 | Ferro Corporation | Decorative glass enamels |
| NL1013456C2 (nl) * | 1999-11-02 | 2001-05-03 | Dsm Nv | Kristallijn melamine en de toepassing in aminoformaldehydeharsen. |
| US6455525B1 (en) | 1999-11-04 | 2002-09-24 | Cephalon, Inc. | Heterocyclic substituted pyrazolones |
| HRP20020547B1 (hr) | 1999-12-24 | 2011-06-30 | Aventis Pharma Limited | Azaindoli |
| US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| WO2001047883A1 (fr) * | 1999-12-27 | 2001-07-05 | Japan Tobacco Inc. | Composes a cycles accoles et leur utilisation comme medicaments |
| WO2001051487A1 (en) | 1999-12-28 | 2001-07-19 | Pfizer Products Inc. | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| GB0003397D0 (en) * | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
| AU2001261377A1 (en) | 2000-05-10 | 2001-11-20 | Smith Kline Beecham Corporation | Novel anti-infectives |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| US6940392B2 (en) * | 2001-04-24 | 2005-09-06 | Savi Technology, Inc. | Method and apparatus for varying signals transmitted by a tag |
| US6765484B2 (en) * | 2000-09-07 | 2004-07-20 | Savi Technology, Inc. | Method and apparatus for supplying commands to a tag |
| ATE526339T1 (de) | 2001-01-22 | 2011-10-15 | Merck Sharp & Dohme | Nukleosidderivate als inhibitoren der rna- abhängigen viralen rna-polymerase |
| GB0102109D0 (en) | 2001-01-26 | 2001-03-14 | Syngenta Ltd | Chemical process |
| AU2002252183A1 (en) | 2001-03-06 | 2002-09-19 | Biocryst Pharmaceuticals, Inc. | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases |
| IL157280A0 (en) * | 2001-03-08 | 2004-02-19 | Boehringer Ingelheim Ca Ltd | Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| EP1256628A3 (en) | 2001-05-10 | 2003-03-19 | Agouron Pharmaceuticals, Inc. | Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof |
| AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
| EP1395571A1 (en) | 2001-06-11 | 2004-03-10 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| JP4544857B2 (ja) | 2001-06-11 | 2010-09-15 | ヴァイロケム ファーマ インコーポレイテッド | Ｆｌａｖｉｖｉｒｕｓ感染の治療または予防のための化合物および方法 |
| GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| JP2003212846A (ja) * | 2001-06-26 | 2003-07-30 | Japan Tobacco Inc | 縮合環化合物及びｃ型肝炎治療剤 |
| AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
| JP4558314B2 (ja) * | 2001-07-20 | 2010-10-06 | ベーリンガー インゲルハイム （カナダ） リミテッド | ウイルスポリメラーゼインヒビター |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| US7294457B2 (en) * | 2001-08-07 | 2007-11-13 | Boehringer Ingelheim (Canada) Ltd. | Direct binding assay for identifying inhibitors of HCV polymerase |
| IL160043A0 (en) * | 2001-08-22 | 2004-06-20 | Ciba Sc Holding Ag | Process for the preparation of indole derivatives |
| WO2003026587A2 (en) | 2001-09-26 | 2003-04-03 | Bristol-Myers Squibb Company | Compounds useful for treating hepatitus c virus |
| UA79248C2 (en) | 2001-11-09 | 2007-06-11 | Janssen Pharmaceutica Nv | Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| US7196111B2 (en) | 2002-06-04 | 2007-03-27 | Schering Corporation | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| US7098231B2 (en) * | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7286844B1 (en) * | 2003-01-31 | 2007-10-23 | Bbn Technologies Corp. | Systems and methods for three dimensional antenna selection and power control in an Ad-Hoc wireless network |
| GB0307891D0 (en) | 2003-04-04 | 2003-05-14 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
| JP2007501189A (ja) | 2003-08-01 | 2007-01-25 | ジェネラブス テクノロジーズ，インコーポレイテッド | フラビウイルス科に対する二環式イミダゾール誘導体 |
| WO2005014543A1 (ja) | 2003-08-06 | 2005-02-17 | Japan Tobacco Inc. | 縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用 |
| US7136667B2 (en) * | 2003-10-28 | 2006-11-14 | Nokia Corporation | Method and radio terminal equipment arrangement for power control, radio terminal equipment and secondary terminal unit |
| US7212122B2 (en) * | 2003-12-30 | 2007-05-01 | G2 Microsystems Pty. Ltd. | Methods and apparatus of meshing and hierarchy establishment for tracking devices |
| PT1718608E (pt) | 2004-02-20 | 2013-08-01 | Boehringer Ingelheim Int | Inibidores da polimerase viral |
| NZ550177A (en) * | 2004-03-08 | 2010-08-27 | Boehringer Ingelheim Pharma | Process for cross coupling indoles |
| US7126009B2 (en) * | 2004-03-16 | 2006-10-24 | Boehringer Ingelheim International, Gmbh | Palladium catalyzed indolization of 2-bromo or chloroanilines |
| US7348875B2 (en) * | 2004-05-04 | 2008-03-25 | Battelle Memorial Institute | Semi-passive radio frequency identification (RFID) tag with active beacon |
| UY29017A1 (es) * | 2004-07-16 | 2006-02-24 | Boehringer Ingelheim Int | Inhibidores de polimerasa viral |
| US7319397B2 (en) * | 2004-08-26 | 2008-01-15 | Avante International Technology, Inc. | RFID device for object monitoring, locating, and tracking |
| US7342497B2 (en) * | 2004-08-26 | 2008-03-11 | Avante International Technology, Inc | Object monitoring, locating, and tracking system employing RFID devices |
| RU2466126C2 (ru) * | 2005-02-11 | 2012-11-10 | Берингер Ингельхайм Интернациональ Гмбх | Способ получения 2,3-дизамещенных индолов |
-
2002
- 2002-02-18 EP EP10185316A patent/EP2335700A1/en not_active Withdrawn
- 2002-07-18 KR KR1020097024619A patent/KR101031183B1/ko not_active Expired - Fee Related
- 2002-07-18 SI SI200230673T patent/SI1414441T1/sl unknown
- 2002-07-18 PL PL02368357A patent/PL368357A1/xx not_active Application Discontinuation
- 2002-07-18 IL IL15954502A patent/IL159545A0/xx unknown
- 2002-07-18 ES ES02750715T patent/ES2299588T3/es not_active Expired - Lifetime
- 2002-07-18 HR HR20040072A patent/HRP20040072B1/xx not_active IP Right Cessation
- 2002-07-18 EP EP07117946A patent/EP1891950A1/en not_active Withdrawn
- 2002-07-18 CA CA002450033A patent/CA2450033C/en not_active Expired - Fee Related
- 2002-07-18 EP EP02750715A patent/EP1414441B1/en not_active Expired - Lifetime
- 2002-07-18 PT PT02752904T patent/PT1414797E/pt unknown
- 2002-07-18 NZ NZ531229A patent/NZ531229A/xx not_active IP Right Cessation
- 2002-07-18 CN CNB028187970A patent/CN100443469C/zh not_active Expired - Fee Related
- 2002-07-18 US US10/198,680 patent/US7157486B2/en not_active Expired - Lifetime
- 2002-07-18 KR KR1020047001069A patent/KR100950868B1/ko not_active Expired - Fee Related
- 2002-07-18 HR HR20090668A patent/HRP20090668A2/hr not_active Application Discontinuation
- 2002-07-18 PT PT02750715T patent/PT1414441E/pt unknown
- 2002-07-18 UA UA2004021313A patent/UA84256C2/ru unknown
- 2002-07-18 DK DK02752904T patent/DK1414797T3/da active
- 2002-07-18 CN CN028187903A patent/CN1558759B/zh not_active Expired - Fee Related
- 2002-07-18 MX MXPA04000729A patent/MXPA04000729A/es active IP Right Grant
- 2002-07-18 CN CN2011103245986A patent/CN102424680A/zh active Pending
- 2002-07-18 ES ES02752904T patent/ES2299591T3/es not_active Expired - Lifetime
- 2002-07-18 MX MXPA04000731A patent/MXPA04000731A/es active IP Right Grant
- 2002-07-18 JP JP2003515500A patent/JP4398725B2/ja not_active Expired - Fee Related
- 2002-07-18 KR KR1020047001061A patent/KR100949446B1/ko not_active Expired - Fee Related
- 2002-07-18 SG SG2006005433A patent/SG176999A1/en unknown
- 2002-07-18 EA EA200400114A patent/EA007722B1/ru not_active IP Right Cessation
- 2002-07-18 HU HU0402065A patent/HUP0402065A3/hu unknown
- 2002-07-18 WO PCT/CA2002/001127 patent/WO2003010140A2/en not_active Ceased
- 2002-07-18 AT AT02750715T patent/ATE382348T1/de active
- 2002-07-18 WO PCT/CA2002/001128 patent/WO2003010141A2/en not_active Ceased
- 2002-07-18 DK DK02750715T patent/DK1414441T3/da active
- 2002-07-18 JP JP2003515499A patent/JP4398241B2/ja not_active Expired - Fee Related
- 2002-07-18 DE DE60224401T patent/DE60224401T2/de not_active Expired - Lifetime
- 2002-07-18 CA CA2449180A patent/CA2449180C/en not_active Expired - Fee Related
- 2002-07-18 PL PL02372125A patent/PL372125A1/xx unknown
- 2002-07-18 ME MEP-621/08A patent/MEP62108A/xx unknown
- 2002-07-18 HU HU0401784A patent/HUP0401784A3/hu unknown
- 2002-07-18 AU AU2002313410A patent/AU2002313410B2/en not_active Ceased
- 2002-07-18 NZ NZ531267A patent/NZ531267A/en not_active IP Right Cessation
- 2002-07-18 AU AU2002355150A patent/AU2002355150B2/en not_active Ceased
- 2002-07-18 RS YUP-69/04A patent/RS51083B/sr unknown
- 2002-07-18 BR BR0211477-1A patent/BR0211477A/pt not_active IP Right Cessation
- 2002-07-18 BR BR0211360-0A patent/BR0211360A/pt not_active IP Right Cessation
- 2002-07-18 EP EP02752904A patent/EP1414797B9/en not_active Expired - Lifetime
- 2002-07-18 EA EA200400113A patent/EA007715B1/ru not_active IP Right Cessation
- 2002-07-18 ME MEP-596/08A patent/MEP59608A/xx unknown
- 2002-07-18 DE DE60224400T patent/DE60224400T2/de not_active Expired - Lifetime
- 2002-07-18 RS YUP-70/04A patent/RS50843B/sr unknown
- 2002-07-18 EP EP07117984A patent/EP1891951A1/en not_active Withdrawn
- 2002-07-18 HR HR20040073A patent/HRP20040073B1/xx not_active IP Right Cessation
- 2002-07-18 IL IL15964902A patent/IL159649A0/xx not_active IP Right Cessation
- 2002-07-18 RS RSP-2009/0517A patent/RS20090517A/sr unknown
- 2002-07-18 SI SI200230674T patent/SI1414797T1/sl unknown
- 2002-07-18 US US10/198,384 patent/US7141574B2/en not_active Expired - Lifetime
- 2002-07-18 AT AT02752904T patent/ATE382605T1/de active
- 2002-07-23 MY MYPI20022780 patent/MY151080A/en unknown
- 2002-07-25 AR ARP020102801A patent/AR037495A1/es not_active Application Discontinuation
- 2002-07-25 UY UY27397A patent/UY27397A1/es not_active Application Discontinuation
- 2002-07-25 PE PE2002000663A patent/PE20030305A1/es not_active Application Discontinuation
-
2003
- 2003-12-24 IL IL159545A patent/IL159545A/en not_active IP Right Cessation
-
2004
- 2004-01-21 NO NO20040282A patent/NO327055B1/no not_active IP Right Cessation
- 2004-01-23 CO CO04005122A patent/CO5650161A2/es not_active Application Discontinuation
- 2004-01-23 NO NO20040322A patent/NO333121B1/no not_active IP Right Cessation
- 2004-01-27 CO CO04005915A patent/CO5650162A2/es active IP Right Grant
-
2006
- 2006-01-17 US US11/333,163 patent/US7576079B2/en not_active Expired - Lifetime
- 2006-08-15 US US11/464,651 patent/US7803944B2/en not_active Expired - Lifetime
-
2008
- 2008-03-21 CY CY20081100332T patent/CY1107355T1/el unknown
- 2008-03-21 CY CY20081100331T patent/CY1107354T1/el unknown
- 2008-11-26 US US12/323,961 patent/US7893084B2/en not_active Expired - Lifetime
-
2009
- 2009-03-02 JP JP2009048600A patent/JP2009120616A/ja not_active Withdrawn
- 2009-04-06 JP JP2009092397A patent/JP2009275037A/ja not_active Withdrawn
- 2009-08-21 AR ARP090103220A patent/AR073106A2/es unknown
-
2012
- 2012-10-30 IL IL222761A patent/IL222761A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537564A5 (cg-RX-API-DMAC7.html) | ||
| CA2449180A1 (en) | Viral polymerase inhibitors | |
| JP3887769B2 (ja) | 対称および非対称ジフェニル尿素を用いるｐ３８キナーゼの阻害 | |
| EP1077700B1 (en) | BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE | |
| JP4359817B2 (ja) | ｐ３８阻害剤としての窒素ヘテロ原子含有ヘテロアリール尿素 | |
| JP6532878B2 (ja) | 組合せ医薬 | |
| CA2448737A1 (en) | Viral polymerase inhibitors | |
| US10130629B2 (en) | Pharmaceutical combinations | |
| AU2016243631B2 (en) | Methods of administering glutaminase inhibitors | |
| CA2369560A1 (en) | Agent for prophylaxis and treatment of liver disease | |
| CA2471099A1 (en) | .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors | |
| CA2443918A1 (en) | Visual function disorder improving agents containing rho kinase inhibitors | |
| US20120108592A1 (en) | Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses | |
| CA2422354A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
| RU2020112759A (ru) | Гетероциклические соединения в качестве ингибиторов PAD | |
| US20030100582A1 (en) | Benzimidazole compounds for regulating IgE | |
| RU2004125279A (ru) | Новые пептиды, как ингибиторы ns3-серинпротеазы вируса гепатита c | |
| CA2511307A1 (en) | Viral polymerase inhibitors | |
| AU2005294320A1 (en) | Combination of organic compounds | |
| RU2005116254A (ru) | Производные пиридопирролизина и пиридоиндолизина | |
| RU2005113168A (ru) | Производные 2-пиридона в качестве ингибитора нейтрофильной эластазы | |
| JP2008510828A5 (cg-RX-API-DMAC7.html) | ||
| RU2006137716A (ru) | Ингибиторы гистондеацетилазы | |
| CA2439410A1 (en) | Analogs of thalidomide as potential angiogenesis inhibitors | |
| JP2004523561A5 (cg-RX-API-DMAC7.html) |